E.S. Vesell
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Metabolism and Genetic Disorders
Papers in
-
- Diet and metabolism studies 3
-
- Nicotinic Acetylcholine Receptors Study 3
- Co-authors
- Barry Dvorchik (3 shared papers)Gabriel A. Kyerematen (3 shared papers)J.D. deBethizy (2 shared papers)G. Thomas Passananti (4 shared papers)Carol A. Shively (3 shared papers)D. E. Rannels (2 shared papers)James P. Fabisiak (2 shared papers)John G. Page (1 shared paper)
- Journals
- Pharmacology (6 papers)Drug Metabolism and Disposition (6 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Cancer (1 paper)Life Sciences (1 paper)
- Partner nations
- United StatesGermany
In The Last Decade
E.S. Vesell
21 papers receiving 484 citations
Peers
Comparison fields: 5 of 89
- Pharmacology 143
- Clinical Biochemistry 32
- Biochemistry 33
- Cellular and Molecular Neuroscience 81
- Physiology 98
Countries citing papers authored by E.S. Vesell
This map shows the geographic impact of E.S. Vesell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.S. Vesell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.S. Vesell more than expected).
Fields of papers citing papers by E.S. Vesell
This network shows the impact of papers produced by E.S. Vesell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.S. Vesell. The network helps show where E.S. Vesell may publish in the future.
Co-authors
The 24 scholars most cited alongside E.S. Vesell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 80 | |
| 2 | 1968 | 77 | |
| 3 | 1976 | 67 | |
| 4 | 1988 | 57 | |
| 5 | 1973 | 46 | |
| 6 | 1987 | 30 | |
| 7 | 1969 | 22 | |
| 8 | 1989 | 18 | |
| 9 | 1989 | 17 | |
| 10 | 1992 | 17 | |
| 11 | 1972 | 15 | |
| 12 | 1978 | 14 | |
| 13 | 1993 | 13 | |
| 14 | 1989 | 11 | |
| 15 | 1972 | 8 | |
| 16 | 1987 | 7 | |
| 17 | 1987 | 7 | |
| 18 | 1978 | 4 | |
| 19 | 1992 | 3 | |
| 20 | 1989 | 2 |
About E.S. Vesell
E.S. Vesell is a scholar working on Physiology, Molecular Biology, Pharmacology, Biochemistry and Clinical Biochemistry, having authored 21 papers that have together received 517 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Metabolism and Genetic Disorders (4 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Diet and metabolism studies (3 papers), Synthesis and Biological Evaluation (2 papers), Inhalation and Respiratory Drug Delivery (2 papers), Amino Acid Enzymes and Metabolism (2 papers) and Neonatal Health and Biochemistry (2 papers). The work is most often cited by research in Pharmacology (143 citations), Clinical Biochemistry (32 citations), Biochemistry (33 citations), Cellular and Molecular Neuroscience (81 citations) and Physiology (98 citations). E.S. Vesell has collaborated with scholars based in United States and Germany. Frequent co-authors include Barry Dvorchik, Gabriel A. Kyerematen, J.D. deBethizy, G. Thomas Passananti, Carol A. Shively, D. E. Rannels, James P. Fabisiak, John G. Page, Mark Seaton and Alexander G. Karczmar. Their work appears in journals such as Pharmacology, Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, Cancer and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.